Dendreon Opens It First Clinical Trial in the European Union
On September 27th Dendreon announced that it has enrolled and started its first patient with metastatic advanced prostate cancer that is castrate resistanr in a European Union based clinical trial of Provenge. Finally, men in [...]
A Common Advanced Prostate Cancer Emergency – Spinal Cord Compression
Spinal cord compression is not an uncommon occurrence in men with advanced prostate cancer. Bones are the most common target of advanced prostate cancer, including the spine. Sadly, there is often a delay in diagnosing [...]
How To Dispose of Unneeded Medications
We all manage to accumulate prescription and non-prescription medications that we no longer need. They can sit in our medicine chests accumulating dust or even be stolen and sold for illegal use. Some people just [...]
Coming in Early 2013 – A Genetic Test to Predict Which Prostate Cancers Need treatment and Which can be Subject to Active Surveillance
Genomic Health, Inc. has announced they have had positive results from a large clinical validation study of a biopsy-based prostate cancer test designed to predict adverse pathology in men with early prostate cancer. The study, [...]
Can Tamoxifen Manage Breast Events Induced by Non-Steroidal Antiandrogens in Men with Advanced Prostate Cancer?
Many of us who are fighting advanced prostate cancer struggle with the perplexing side effects of non-steroidal antiandrogens (like Casodex). These side effects include gynecomastia (breast enlargement) and breast pain. In most cases as we [...]
Sharecare Honors Ten Prostate Cancer Influencers, Including Me!
Yesterday, I was given the honor of being named as one of the ten “influencers” in prostate cancer. The honor was extended by sharecare.org (twitter- Sharecare ?@SharecareNow ). Sharecare is active in many health issues, [...]